N-Methyl-DOI

Last updated

N-Methyl-DOI
N-Methyl-DOI.svg
Clinical data
Other names2,5-Dimethoxy-4-iodo-N-methylamphetamine; 4-Iodo-2,5-dimethoxy-N-methylamphetamine; 2,5-IDNA; N-Me-DOI
Drug class Serotonin receptor modulator; Serotonin 5-HT2A receptor partial agonist
ATC code
  • None
Identifiers
  • 1-(4-iodo-2,5-dimethoxyphenyl)-N-methylpropan-2-amine
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
Formula C12H18INO2
Molar mass 335.185 g·mol−1
3D model (JSmol)
  • CC(CC1=CC(=C(C=C1OC)I)OC)NC
  • InChI=1S/C12H18INO2/c1-8(14-2)5-9-6-12(16-4)10(13)7-11(9)15-3/h6-8,14H,5H2,1-4H3
  • Key:UFHCKYRPMINDBF-UHFFFAOYSA-N

N-Methyl-DOI, also known as 2,5-dimethoxy-4-iodo-N-methylamphetamine (2,5-IDNA), is a serotonin receptor modulator of the phenethylamine, amphetamine, and DOx families related to the serotonergic psychedelic DOI. [1] [2] It is a potent agonist of the serotonin 5-HT2A receptor similarly to DOI. [1] However, N-methyl-DOI was about 3.8-fold less potent than DOI as a serotonin 5-HT2A receptor agonist in terms of EC50 Tooltip half-maximal effective concentration and showed reduced maximal efficacy compared to DOI (Emax Tooltip maximal efficacy = 64% vs. 83%). [1] On the other hand, it showed similar efficacy in activating the serotonin 5-HT2A receptor to the psychedelic 2C-I (Emax = 68%). [1] N-Methyl-DOI was first described in the scientific literature, as a potential radiopharmaceutical for medical imaging, by Alexander Shulgin and colleagues by 1984. [3]

Contents

See also

References

  1. 1 2 3 4 McCorvy JD (16 January 2013). Mapping the binding site of the 5-HT2A receptor using mutagenesis and ligand libraries: Insights into the molecular actions of psychedelics (Ph.D. thesis). Purdue University. Archived from the original on 15 May 2025. Retrieved 27 May 2025– via Purdue e-Pubs.{{cite thesis}}: CS1 maint: bot: original URL status unknown (link)
  2. ↑ Shulgin A, Manning T, Daley P (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds . Vol. 1. Berkeley: Transform Press. ISBN   978-0-9630096-3-0.
  3. ↑ Sargent T, Shulgin AT, Mathis CA (August 1984). "Radiohalogen-labeled imaging agents. 3. Compounds for measurement of brain blood flow by emission tomography". Journal of Medicinal Chemistry. 27 (8): 1071–1077. doi:10.1021/jm00374a023. PMID   6611416.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.